The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia.
J Obstet Gynaecol Res. 2023 Apr;49(4):1090-1105. doi: 10.1111/jog.15549. Epub 2023 Feb 6.
Endometriosis is a serious, chronic disorder where endometrial tissue grows outside the uterus, causing severe pelvic pain and infertility. It affects 11% of women. Endometriosis is a multifactorial disorder of unclear etiology, although retrograde menstruation plays a major role. It has a genetic component with over 40 genetic risk factors mapped, although their mechanism of action is still emerging. New evidence suggests a role for retrograde menstruation of endometrial stem/progenitor cells, now that identifying markers of these cells are available. Recent lineage tracing and tissue clearing microscopy and 3D reconstruction has provided new understanding of endometrial glandular structure, particularly the horizontal orientation and interconnection of basalis glands. New sequencing technologies, particularly whole genome DNA sequencing are revealing somatic mutations, including in cancer driver genes, in normal and eutopic endometrium of patients with endometriosis, as well as ectopic endometriotic lesions. Methylome sequencing is offering insight into the regulation of genes and the role of the environmental factors. Single cell RNA sequencing reveals the transcriptome of individual endometrial cells, shedding new light on the diversity and range of cellular subpopulations of the major cell types present in the endometrium and in endometriotic lesions. New endometrial epithelial organoid cultures replicating glandular epithelium are providing tractable models for studying endometriosis. Organoids derived from menstrual fluid offer a non-invasive source of endometrial tissue and a new avenue for testing drugs and developing personalized medicine for treating endometriosis. These new approaches are rapidly advancing our understanding of endometriosis etiology.
子宫内膜异位症是一种严重的慢性疾病,其子宫内膜组织生长在子宫外,导致严重的盆腔疼痛和不孕。它影响了 11%的女性。子宫内膜异位症是一种病因不明的多因素疾病,尽管逆行性月经起主要作用。它具有遗传成分,已有超过 40 个遗传风险因素被定位,但它们的作用机制仍在出现。新的证据表明,子宫内膜干细胞/祖细胞的逆行月经可能起作用,因为现在可以识别这些细胞的标志物。最近的谱系追踪和组织透明显微镜和 3D 重建为子宫内膜腺结构提供了新的认识,特别是基底层腺的水平取向和互连。新的测序技术,特别是全基因组 DNA 测序,揭示了体细胞突变,包括在癌症驱动基因中,在子宫内膜异位症患者的正常和在位子宫内膜以及异位子宫内膜病变中。甲基组测序提供了对基因调控和环境因素作用的深入了解。单细胞 RNA 测序揭示了单个子宫内膜细胞的转录组,为子宫内膜和子宫内膜异位病变中主要细胞类型的细胞亚群的多样性和范围提供了新的认识。新的子宫内膜上皮类器官培养物复制腺上皮,为研究子宫内膜异位症提供了可行的模型。来源于月经血的类器官提供了非侵入性的子宫内膜组织来源,为测试药物和开发治疗子宫内膜异位症的个体化药物提供了新途径。这些新方法正在迅速推进我们对子宫内膜异位症病因的理解。